Translating Molecular Technologies into Routine Newborn Screening Practice

As biotechnologies advance and better treatment regimens emerge, there is a trend toward applying more advanced technologies and adding more conditions to the newborn screening (NBS) panel. In the current Recommended Uniform Screening Panel (RUSP), all conditions but one, congenital hypothyroidism,...

Descripción completa

Detalles Bibliográficos
Autores principales: Furnier, Sarah M., Durkin, Maureen S., Baker, Mei W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712315/
https://www.ncbi.nlm.nih.gov/pubmed/33124618
http://dx.doi.org/10.3390/ijns6040080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712315/
https://www.ncbi.nlm.nih.gov/pubmed/33124618
http://dx.doi.org/10.3390/ijns6040080

Ejemplares similares